Skip to main content

Adverum Biotechnologies, Inc.

ADVMDelisted Dec 9, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001501756

Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.

Q4 2024 vs. Q3 2024

How the institutions holding Adverum Biotechnologies, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of ADVM: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders7770−7
Shares16.9M15.9M−1.07M (−6.3%)
Value$120.2M$74.1M−$46.0M (−38.3%)

New holders (10)

Institutions that held Adverum Biotechnologies, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to ADVM in Q4 2024
InstitutionSharesValue% of portfolio
Principia Wealth Advisory, LLC1,330,660$6.21M5.84%
Regeneron Pharmaceuticals, Inc.180,909$844.8K0.08%
D. E. Shaw & Co., Inc.47,614$222.4K0.00%
Corton Capital Inc.32,696$152.7K0.09%
Police & Firemen's Retirement System of New Jersey4,182$19.5K0.00%
Simplex Trading, LLC1,994$9.00K0.00%
R Squared Ltd710$3.32K0.00%
SBI Securities Co., Ltd.85$3970.00%
Caitong International Asset Management Co., Ltd44$2050.00%
IFP Advisors, Inc0$190.00%

Sold out (17)

Institutions that held Adverum Biotechnologies, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.